Tandem Diabetes Care Inc (TNDM)
Pretax margin
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Earnings before tax but after interest (EBT) | US$ in thousands | -220,254 | -92,852 | 15,901 | -36,282 | -24,604 |
| Revenue | US$ in thousands | 735,632 | 795,009 | 696,759 | 486,025 | 362,227 |
| Pretax margin | -29.94% | -11.68% | 2.28% | -7.47% | -6.79% |
December 31, 2023 calculation
Pretax margin = EBT ÷ Revenue
= $-220,254K ÷ $735,632K
= -29.94%
The pretax margin of Tandem Diabetes Care Inc has exhibited fluctuations over the past five years. In 2023, the company reported a pretax margin of -29.46%, indicating that for every dollar of revenue generated, the company incurred 29.46 cents in pretax losses. This represents a significant decline compared to the previous year's pretax margin of -11.59%.
The pretax margin was positive in 2021 at 2.26%, reflecting a period of profitability with the company earning 2.26 cents in pretax profit for every dollar of revenue. However, in 2020 and 2019, the company experienced negative pretax margins of -7.27% and -6.79% respectively, indicating losses before tax in those years.
Overall, the trend in the pretax margin of Tandem Diabetes Care Inc suggests volatility and inconsistency in its operational performance and financial health over the past five years. It is important for the company to closely monitor its cost structure, revenue generation, and overall efficiency to improve its profitability and financial stability in the future.
Peer comparison
Dec 31, 2023